We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
L.A Brewery (LAB) produces non-alcoholic kombucha made from health-boosting teas, fruits, and botanicals. LAB argues that 25% of drinkers consider themselves semi-regular consumers of low and no alcohol in the UK and aims to cater to the demands of this category. LAB asserts that it has already produced and sold one million drinks and achieved listings with entities like Amazon, Selfridges, Leon, Farmdrop, Wholefoods, Planet Organic, Ocado (March 2021), and 300+ independent stockists across the UK. It has also featured in Vogue, GQ, Tatler, Hello!, Elle, and Glamour, to name a few. LAB points out that its feature on ITV's 'Love Your Weekend' with Alan Titchmarsh resulted in £1,000+ worth of online sales in 10 minutes. It will use the investment to expand its microbrewery, increase production 4 times to meet future demand, and increase brand awareness.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,349,997
The Park Brewery (TPB) is a beer manufacturer. The company raised over £300,000 in its crowdfunding campaign in 2018. It has also managed to increase its sales from 100 pubs to 200. The company's beer is distributed around the UK via eight wholesalers. It also has onboarded notable clients like The Hilton, Honest Burgers, Fullers, and many more. TPB argues that it performed well despite Covid-19. It set up an e-commerce site and sold its products Direct-to-Customers (DTC), having completed around 2,000 home deliveries and gained over 1,700 new customers in 2020 throughout the lockdown. It will use the investment to develop its marketing strategy, increase direct sales, enhance its range, create more employment, and purchase additional tank space to meet demand.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £229,999
WeVee is a platform that brings Electric Vehicles (EVs) into one place so that potential customers can browse across different models and makes, compare them, get relevant pricing, and configure a leasing plan, with the help of reliable EV experts. The company asserts that its pricing configurator pulls from some of the UK's top lenders such as Lex Autolease, LeasePlan, Arval UK, and ALD Automotive, using Application Programming Interface (API's) to show the best price for each lease configuration. WeVee argues that over 800 vehicles have been ordered on its portal to date. It has also earned £830,000 worth of revenue since launch and garnered 350+ 5-star Trustpilot reviews. WeVee will use the investment for technology development, marketing, contingency purposes, towards paying its tech, leadership, marketing, and operations teams, and upgrades to its IT hardware.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,602,196
Vertically Urban (VU) is a horticultural lighting specialist that produces high-tech LED lighting solutions for indoor industrial farms, glasshouses, medicinal growers and onsite Pod farms, who in turn, supply to supermarkets, restaurants and the medical market. The company aims to be a segment leader in the global vertical farming market that is projected to reach $12.7 billion by 2026. VU asserts that vertical farming has been tipped as the future of food production and supported by early investors such as Amazon’s Jeff Bezos. The company has witnessed £30 million+ worth of sales to date. It will use the investment to increase brand awareness via horticultural trade shows, market its products on online and offline portals, develop new technologies, and recruit senior personnel to oversee growth in key markets.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £335,040
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph